Hong Kong Stock Movement | CONANT OPTICAL (02276) Rises Over 5% as Meta Plans to Double AI Smart Glasses Production Capacity; Company Benefits from Accelerated Industry Chain Development

Stock News
01/14

CONANT OPTICAL (02276) rose over 5%, and as of the time of writing, it was up 5.36%, trading at HKD 55.05 with a turnover of HKD 27.6336 million. On the news front, Meta Platforms and EssilorLuxottica are reportedly discussing a plan to double the production capacity of AI smart glasses by the end of this year, aiming to capture growing demand and establish a presence ahead of competitors. According to informed sources, as sales of the Ray-Ban Meta smart glasses gradually ramp up, Meta has proposed increasing the annual production capacity to 20 million units or more by the end of 2026. Guotai Haitong Securities noted in a research report that, according to Counterpoint Research, global smart glasses shipments in the first half of 2025 increased by 110% year-on-year, maintaining rapid growth. The inclusion of smart glasses in national subsidies for the first time is expected to bring incremental demand. Huachuang Securities stated in its research report that CONANT OPTICAL has deep roots in the eyewear manufacturing industry, with simultaneous progress in domestic and international sales, and that structural upgrades are expected to drive continuous improvement in profitability. The company has already collaborated with several leading 3C manufacturers to develop smart glasses, indicating promising growth prospects. Considering the accelerated development of the smart glasses industry chain coupled with the steady upward trend in the company's product mix, the brokerage forecasts the company's net profit attributable to parents for 2025-2027 to be RMB 560 million, RMB 700 million, and RMB 870 million, respectively, corresponding to a PE ratio of 41x, 34x, and 27x.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10